Assignee
CELLARTGEN INC
KR·4 granted patents·16 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
20 records- 0162US2024026268A1Microfluidic hanging drop culture device for culturing cell aggregateCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 0259US2023201109A1Bio-inspired tissue-adhesive hydrogel patch for preventing or treating cartilage or bone diseaseCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 0356US2024142438A1Multi-organ modelCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 0456US2024228973A9Non-alcoholic fatty liver artificial tissue modelCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 0555US2023355518A1Decellularized tissue-derived extracellular matrix functionalized with phenol derivative and use thereofCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 0655US2023374465A1Esophagus extracellular matrix-derived scaffold for culture and transplantation of esophageal organoid, and method of preparing the sameCELLARTGEN INC·Filed 2021·Application pending·0 cites
- 0754US2023310715A1Extracellular matrix-loaded bio-inspired tissue-adhesive hydrogel patchCELLARTGEN INC·Filed 2021·Application pending·0 cites
- 0853US12569451B2Bio-inspired tissue-adhesive hydrogel patch and uses thereofCELLARTGEN INC·Filed 2019·Granted Mar 10, 2026·0 cites·11 claims
- 0953US2023293768A1Tissue gell for transplantation using decellularized extracellular matrix and method of preparing the sameCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 1052US12540297B2Microfluidic device for cerebrovascular simulation and high-efficiency blood-brain barrier simulation system comprising sameCELLARTGEN INC·Filed 2019·Granted Feb 3, 2026·0 cites·14 claims
- 1152US11725173B2Highly efficient organoid culture device and systemCELLARTGEN INC·Filed 2019·Granted Aug 15, 2023·0 cites·11 claims
- 1252US2023340422A1Adipose extracellular matrix-derived scaffold for culturing organoid and preparing method thereofCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 1351US2024016971A1Phenol derivative-modified, tissue-derived extracellular matrix derivative for construction of artificial tissueCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 1448US2024191222A1Tissue-derived extracellular matrix derivative modified with acryl group and use thereofCELLARTGEN INC·Filed 2022·Application pending·0 cites
- 1546US12534704B2Organ extracellular matrix-derived scaffold for culture and transplantation of organoid and method of preparing the sameCELLARTGEN INC·Filed 2021·Granted Jan 27, 2026·0 cites·1 claims
- 1645US2024026300A1Kidney extracellular matrix-derived scaffold for culture and transplantation of kidney organoid and method of preparing the sameCELLARTGEN INC·Filed 2021·Application pending·0 cites
- 1745US2023399624A1Pancreas extracellular matrix derived scaffold for culture and transplantation of pancreatic organoid and method of preparing the sameCELLARTGEN INC·Filed 2021·Application pending·0 cites
- 1844US2022143190A1Hydrogel comprising hyaluronic acid modified by serotonin and uses thereofCELLARTGEN INC·Filed 2020·Application pending·0 cites
- 1944US2023285315A1Exosome-loaded bio-inspired tissue-adhesive hydrogel patchCELLARTGEN INC·Filed 2021·Application pending·0 cites
- 2041US2023108699A1Heart extracellular matrix-derived scaffold for culture and transplantation of cardiac organoid and method of preparing the sameCELLARTGEN INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CELLARTGEN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →